Related Experiment Video
Updated: Nov 4, 2025

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Expanding the clinical spectrum in trichohepatoenteric syndrome
1Division of Metabolism, Department of Pediatrics, University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey.
Insights
Trichohepatoenteric syndrome (THES) is a rare genetic disorder. This study presents two sibling cases, highlighting a new TTC37 gene variation and expanding the known clinical spectrum of THES.
Area of Science:
- Genetics
- Pediatrics
- Rare Diseases
Background:
- Trichohepatoenteric syndrome (THES) is a rare autosomal recessive disorder.
- Characterized by intractable diarrhea, dysmorphic features, immunodeficiency, and failure to thrive.
- Management challenges persist despite recent molecular discoveries.
Purpose of the Study:
- To present two sibling cases of Trichohepatoenteric syndrome.
- To describe a novel TTC37 gene variation.
- To expand the understanding of THES clinical manifestations.
Main Methods:
- Case study of two siblings diagnosed with THES.
- Genetic analysis to identify variations in the TTC37 gene.
- Clinical evaluation and follow-up of patients.
Main Results:
- One sibling presented a novel TTC37 gene variation (c.2114+5G>A) with a mild clinical course.
- The other sibling was diagnosed at 17 years old, experiencing seizures and sudden death.
- These findings broaden the spectrum of clinical presentations in THES.
Conclusions:
- The presented cases contribute to the clinical variability of Trichohepatoenteric syndrome.
- Identification of a novel TTC37 variation deepens the understanding of THES genetics.
- Further research is needed to improve THES diagnosis and management.
Abstract:
Trichohepatoenteric syndrome (THES) is a very rare autosomal recessive genetic disorder, which is characterized by intractable diarrhea during infancy, dysmorphic features, immunodeficiency, and a failure to thrive. There are still significant difficulties for patients and clinicians in terms of the management of THES, even though its molecular basis has been uncovered in the last decade. In this article, we have presented two cases relating to siblings that have been diagnosed with the condition. Concerning one of the patients, we described a novel variation (c.2114 + 5G > A) in the TTC37 gene and a mild clinical course; meanwhile, the other one was clinically diagnosed with THES at 17 years of age, but they had seizures and died suddenly. These cases expand the spectrum of clinical findings in relation to THES.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
10:57Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children
Published on: August 22, 2012
Related Concept Videos
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...